Role of the pharmacist in cancer care:
Focus on off-label use of chemotherapies
Off-label use in cancer care is an issue for oncology pharmacists given ongoing evolution of therapeutic innovation in this area and cost constraints.
We carry out a survey among oncology pharmacists in different European countries to establish an inventory of pharmacists' intervention in cancer care and compare European practices.
This questionnaire attempts to understand your role as a pharmacist in cancer care, the way you analyse chemotherapy prescriptions and manage an off-label prescription. This survey also focuses on the issue of reimbursement of off-label use in cancer care.
Since the beginning of the study in June, 46 pharmacists, from 25 different countries, have already answered: thank you!
But... the survey is still ongoing for a few days!
We thank pharmacists from Argentina, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Deutschland, Egypt, Estonia, Finland, Iceland, Ireland, Italia, Malta, Morocco, Pakistan, Poland, Portugal, Romania, Scotland, Slovenia, South Africa Spain, Switzerland and The Netherlands who already answered.
As you can see on the map, some countries are not or poorly represented: we count on the participation of pharmacists from these European countries in order to be as comprehensive as possible and representative!